NCT06190028: Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy |
|
|
| Recruiting | N/A | 100 | Europe | Iridium A Gel, Carbopol 0.2% | Fidia Farmaceutici s.p.a. | Dry Eye Syndrome, Glaucoma and Concomitant Dry Eye Syndrome, Ocular Hypertension and Concomitant Dry Eye Syndrome, Multiple Long-term Topical Hypotensive Therapy | 09/24 | 12/24 | | |
